Page last updated: 2024-10-30

meclofenamic acid and Pulmonary Eosinophilia

meclofenamic acid has been researched along with Pulmonary Eosinophilia in 1 studies

Meclofenamic Acid: A non-steroidal anti-inflammatory agent with antipyretic and antigranulation activities. It also inhibits prostaglandin biosynthesis.
meclofenamic acid : An aminobenzoic acid that is anthranilic acid in which one of the hydrogens attached to the nitrogen is replaced by a 2,6-dichloro-3-methylphenyl group. A non-steroidal anti-inflammatory drug, it is used as the sodium salt for the treatment of dysmenorrhoea (painful periods), osteoarthritis and rheumatoid arthritis.

Pulmonary Eosinophilia: A condition characterized by infiltration of the lung with EOSINOPHILS due to inflammation or other disease processes. Major eosinophilic lung diseases are the eosinophilic pneumonias caused by infections, allergens, or toxic agents.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Underwood, DC1
Osborn, RR1
Newsholme, SJ1
Torphy, TJ1
Hay, DW1

Other Studies

1 other study available for meclofenamic acid and Pulmonary Eosinophilia

ArticleYear
Persistent airway eosinophilia after leukotriene (LT) D4 administration in the guinea pig: modulation by the LTD4 receptor antagonist, pranlukast, or an interleukin-5 monoclonal antibody.
    American journal of respiratory and critical care medicine, 1996, Volume: 154, Issue:4 Pt 1

    Topics: Animals; Antibodies, Monoclonal; Bronchoalveolar Lavage Fluid; Bronchoconstriction; Chromones; Cyclo

1996